| 摘要 |
<p>Compounds of formula (I) as defined and their pharmaceutically acceptable salts are inhibitors of α4β1 and/or α4β7 integrins, and are useful in inhibiting cell adhesion and in the therapeutic or prophylactic treatment of transplant rejection and inflammatory and autoimmune diseases.</p> |
